CARLSBAD, Calif., Jan. 5, 2022 /PRNewswire/ -- Ionis
Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that
Brett P. Monia, Ph.D., chief
executive officer, will present a company overview at the virtual
40th Annual J.P. Morgan Healthcare Conference at 9:45
a.m. ET on Wednesday, January 12,
2022.
A live webcast of the presentation will be available on the
Investors & Media section of the Ionis website. The replay will
be available within 48 hours and will be archived for a limited
time.
About Ionis Pharmaceuticals, Inc.
For more than 30
years, Ionis has been the leader in RNA-targeted therapy,
pioneering new markets and changing standards of care with its
novel antisense technology. Ionis currently has three marketed
medicines and a premier late-stage pipeline highlighted by
industry-leading neurological and cardiometabolic franchises. Our
scientific innovation began and continues with the knowledge that
sick people depend on us, which fuels our vision of becoming one of
the most successful biotechnology companies.
To learn more about Ionis visit www.ionispharma.com and
follow us on Twitter @ionispharma.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/ionis-to-present-at-40th-annual-jp-morgan-healthcare-conference-301454178.html
SOURCE Ionis Pharmaceuticals, Inc.